Prasol Chemicals posts ₹989.98 million H1 FY27 profit
Key highlights
- Prasol Chemicals reported ₹989.98 million profit after tax for H1 FY27 on total income of ₹8,487.65 million.
- Prasol Chemicals recorded Q2 FY27 profit after tax of ₹379.75 million and total income of ₹4,134.08 million.
- Prasol Chemicals had total assets of ₹10,707.55 million as of September 30, 2026.
- Prasol Chemicals completed an IPO of 7,396,437 shares at ₹676 per share and listed on September 16, 2026.
powered by IRIS

Prasol Chemicals Limited reported profit after tax of ₹989.98 million on total income of ₹8,487.65 million for the half year ended September 30, 2026, while its September-quarter profit after tax stood at ₹379.75 million. The Board approved the standalone unaudited results on November 2, 2026, shortly after the company completed its initial public offering and stock-market listing.
Know Prasol Chemicals inside out
Results, valuation, peers and who's buying, in one view.
What did Prasol Chemicals report for Q2 and H1 FY27?
Prasol Chemicals reported total income of ₹4,134.08 million for the quarter ended September 30, 2026, with profit after tax of ₹379.75 million. Total expenses for the quarter were ₹3,634.88 million, while profit before tax was ₹499.20 million. Tax expense for the three-month period amounted to ₹119.45 million.
For the half year ended September 30, 2026, total income was ₹8,487.65 million and total expenses were ₹7,152.87 million. Profit before tax was ₹1,334.78 million, followed by tax expense of ₹344.80 million and profit after tax of ₹989.98 million. The disclosed figures are part of the company’s standalone unaudited financial results.
When were the results approved and reviewed?
Prasol Chemicals’ Board of Directors approved the standalone unaudited results at its meeting on November 2, 2026. The Audit Committee reviewed and recommended the financial statements before the Board’s approval. The results cover the July to September quarter and the six months from April to September 2026.
The disclosures include the standalone profit and loss statement, statement of assets and liabilities as of September 30, 2026, and cash flow statement for the half year. The company also received a limited review report from its statutory auditor, CNK & Associates LLP. The auditor issued an unmodified opinion on the standalone unaudited results.
The approval was made under the requirements applicable to listed companies under SEBI Listing Regulations. Prasol Chemicals has said that the financial results are available on its website, www.prasolchem.com.
What do the balance sheet and cash flow figures show?
Prasol Chemicals reported total assets of ₹10,707.55 million as of September 30, 2026. Total equity and liabilities were also ₹10,707.55 million, consistent with the balance sheet structure disclosed alongside the quarterly results.
Net cash generated from operating activities was ₹117.14 million for the half year ended September 30, 2026. This figure represents the cash generated from the company’s operating activities during the period, after the adjustments included in the cash flow statement.
Investing activities resulted in net cash used of ₹360.86 million, primarily due to purchases of property, plant and equipment. Financing activities generated net cash inflow of ₹285.89 million, reflecting borrowings and repayments during the period. Together, these cash flow items show that capital expenditure was a significant use of funds in the half year.
Got a follow-up? Ask IRIS
How did the IPO affect Prasol Chemicals’ financial disclosures?
Prasol Chemicals completed an initial public offering of 7,396,437 equity shares during the September 2026 quarter at an issue price of ₹676 per share. Its shares were listed on the National Stock Exchange of India Limited and BSE Limited on September 16, 2026.
The company disclosed that IPO-related expenses, net of the portion attributable to selling shareholders, amounted to ₹29.27 million. This amount was adjusted against the Securities Premium Account. The treatment is relevant for investors because the expense was recorded through the securities premium account rather than as a charge in the reported quarterly operating expenses.
The listing placed the company under continuing disclosure requirements, including periodic financial reporting and auditor review. The November 2 Board meeting was therefore the first reported half-year financial approval following the September listing date.
What does the result mean for investors and operations?
The reported Q2 and H1 figures provide the first half-year standalone earnings record after Prasol Chemicals’ public listing. Total income of ₹8,487.65 million and profit after tax of ₹989.98 million are the central measures available from the approved financial statement for the April to September period.
For the June 2026 quarter, Prasol Chemicals had reported revenue of ₹4,340 million and net profit of ₹610 million in the information provided. Management had guided for FY27 revenue of ₹15,500 million to ₹16,500 million, operating profit of ₹2,400 million to ₹2,500 million excluding geopolitical price fluctuations and foreign-exchange gains or losses, and blended operating margin of 15% to 16%.
The half-year income figure is below the lower end of the stated full-year revenue guidance, as expected for a six-month reporting period. However, the company has not provided an updated full-year outlook in the disclosed Q2 financial-result information. Investors will therefore have to rely on subsequent management communication for any revision or reaffirmation of its FY27 targets.
Conclusion
Prasol Chemicals’ standalone Q2 and H1 FY27 results show ₹379.75 million profit after tax for the September quarter and ₹989.98 million for the first half, supported by total half-year income of ₹8,487.65 million. The disclosures also show ₹10,707.55 million of total assets, operating cash generation of ₹117.14 million, and investment outflow largely linked to property, plant and equipment purchases.
The next point to watch is management’s discussion of its FY27 revenue target of ₹15,500 million to ₹16,500 million, its operating-profit target of ₹2,400 million to ₹2,500 million, and its 15% to 16% blended operating-margin guidance. Prasol Chemicals had scheduled a Q2 FY27 earnings conference call for November 3, 2026, with Chairman Nishith Shah and CFO Rahul Shroff expected to participate.


